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Asphyxia caused by a lack of oxygen or blood flow to the brain around the time of 
birth affects 1% of infants and 10-20% of these cases develop some degree of hypoxic-
ischemic encephalopathy [1,2] in the developed world whereas the occurrence is 
much higher in underprivileged countries [3].  
Today infants suffering from moderate or severe encephalopathy are offered 
neuroprotective therapy with hypothermia (4) and other therapies are currently being 
developed (3). Therefore, there is a renewed interest in the development of 
biomarkers that can predict the risk of brain injury and aid in the selection of cases 
that should be offered therapy. Previous reports show that MRI/MRS (5) as well as 
multiple biochemical biomarkers in cerebrospinal fluid or neonatal blood hours to 
days after birth are elevated after moderate and severe asphyxia at least if there is 
development of HIE (6-16). However, there is a scarcity of biomarkers detectable in 
readily accessible body fluids such as umbilical blood early enough to be useful for 
directing therapy (17).   
Generally, cases with asphyxia that do not develop moderate or severe 
encephalopathy are considered to have a good long-term prognosis (16,18). However, 
recent studies suggest that there may be a continuum relationship between severity 
of asphyxia and outcome as cognitive outcome seems affected also in cases with mild 
encephalopathy (19) and the school performance was suboptimal in children aged 16 
born with Apgar <7 at 5 min (20). Utilizing new sensitive analytical assays our aim was 
to explore whether the axonal brain injury biomarkers tau and neurofilament light 
(NFL) (Zetterberg H, Blennow K. Nat Rev Neurol. 2016 Oct;12(10):563-74) were 
elevated in umbilical blood at birth in cases with moderate asphyxia (Apgar <7, 5 min 
and metabolic acidosis but not HIE) compared with a non-asphyxiated group of 
newborns.  
 
Materials and methods 
 
The ethical board of the Västra Götaland approved the study protocol (#...). Informed 
consent was provided by all study participants.  
 
 The asphyxia participants included 12 newborns (6 boys, 6 girls; median gestational 
age: 39 weeks)  with neonatal asphyxia (Apgar <7 at 5 min and /or umbilical blood 
acidosis (pH < 7.0). The control group comprised 24 newborns (15 boys, 9 girls; mean 
gestational age 37 weeks) without neonatal asphyxia (Apgar >8 at 5 min and umbilical 
cord pH >7.35). 
 
Umbilical artery and vein blood samples were routinely obtained from study 
participants through a doubly clamped segment of the umbilical cord and collected 
into non-heparinized 5 ml syringes. From these samples, we measured acid base and 
blood gases. After centrifugation,serum samples were collected and frozen and stored 
at 80oC until the assay was performed. 
 
NFL and tau concentrations were measured using ultrasensitive Single molecule array 
(Simoa) assays as previously described in detail (refs: Rohrer JD et al., Neurology. 2016 
Sep 27;87(13):1329-36; Mattsson N et al., Neurology. 2016 Oct 25;87(17):1827-1835). 
The measurements were performed by board-certified laboratory technicians who 
were blinded to clinical information in one round of experiments using one batch of 
reagents. Lower limits of quantification were around 1 pg/mL and intra-assay 
coefficients of variation were below 10%.  
 
Results 
The asphyxia group had a median Apgar of 3 at 1 min,  7 at 5 min and 8 at 10 min 
which was significantly lower than in the control group (Table 1). The mean arterial 
pH was 6.93 and base excess -16.5 in the asphyxia group compared to 7.37 and -1.92, 
respectively, in controls indicating a significant degree of hypoxia in the asphyxia 
group. However, none of the asphyxia cases developed any degree of hypoxic-
ischemic encephalopathy and there was no mortality in any of the groups (check !!).  
The mean serum concentration of tau was 61.8 + 22.3 pg/mL (+ SEM) in the asphyxia 
group compared to 23.2 + 4.3 in the control group (p=0.026). The concentration of 
NFL amounted to 62.5 + 23.0 pg/mL (+ SEM) in the umbilical blood of the asphyxiated 
newborns and 25.2 + 2.1 in the controls (p=0.028).  
 
Discussion 
1. summarize results 
2. no one measured TAU and NFL in umbilical blood before but TAU in neonatal serum 
and NFL in CSF and describe what they found 
3, interesting that brain injury markers are sign increased in spite of moderate degree 
of asphyxia and no HIE supporting that some brain injury may occur even without 
overt signs of HIE and also interesting that these sensitive assays could detect the low 
basal levels of these proteins in the serum as well as the moderate increases seen 
after asphyxia  
4. could mean that these markers could be useful for guiding the clinician regarding 
neuroprotective therapy and  in the future these or similar markers could be analyzed 
in the fetal scalp and if raised could direct the clinician whether the  infant should be 
delivered or not. (maybe not possible to measure in 50 ul of blood ?? and maybe not 
fast enough to be useful for the obstetrician - but maybe in the future) - one of the 
problems with the presently used pH and lactate is the limited specificity  
5. limitations. relatively limited # of cases and only moderately asphyxiated needs to 
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